IL134113A0 - Use of lactobacillus for reduction of the fibrinogen level in blood - Google Patents

Use of lactobacillus for reduction of the fibrinogen level in blood

Info

Publication number
IL134113A0
IL134113A0 IL13411398A IL13411398A IL134113A0 IL 134113 A0 IL134113 A0 IL 134113A0 IL 13411398 A IL13411398 A IL 13411398A IL 13411398 A IL13411398 A IL 13411398A IL 134113 A0 IL134113 A0 IL 134113A0
Authority
IL
Israel
Prior art keywords
lactobacillus
blood
reduction
fibrinogen level
fibrinogen
Prior art date
Application number
IL13411398A
Other languages
English (en)
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of IL134113A0 publication Critical patent/IL134113A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13411398A 1997-08-05 1998-07-30 Use of lactobacillus for reduction of the fibrinogen level in blood IL134113A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702860A SE510753C2 (sv) 1997-08-05 1997-08-05 Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
PCT/SE1998/001423 WO1999007827A1 (en) 1997-08-05 1998-07-30 Use of lactobacillus for reduction of the fibrinogen level in blood

Publications (1)

Publication Number Publication Date
IL134113A0 true IL134113A0 (en) 2001-04-30

Family

ID=20407874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13411398A IL134113A0 (en) 1997-08-05 1998-07-30 Use of lactobacillus for reduction of the fibrinogen level in blood

Country Status (19)

Country Link
US (1) US6214336B1 (xx)
EP (1) EP0990024B1 (xx)
JP (1) JP4651814B2 (xx)
KR (1) KR100517755B1 (xx)
CN (1) CN1142995C (xx)
AR (1) AR016798A1 (xx)
AT (1) ATE326524T1 (xx)
AU (1) AU729413B2 (xx)
BR (1) BR9811825A (xx)
CA (1) CA2297023C (xx)
DE (1) DE69834560T2 (xx)
ES (1) ES2259457T3 (xx)
IL (1) IL134113A0 (xx)
NO (1) NO324881B1 (xx)
NZ (1) NZ502610A (xx)
PL (1) PL194697B1 (xx)
SE (1) SE510753C2 (xx)
WO (1) WO1999007827A1 (xx)
ZA (1) ZA986769B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764011B2 (en) 1998-10-01 2003-08-07 Probi Ab Reduction of oxidative stress factors
JP4193269B2 (ja) * 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
KR20030033950A (ko) * 2001-10-20 2003-05-01 주식회사 알엔에이 유산균 세포질 분획물 또는 유산균 파쇄물을 유효성분으로포함하는 동맥경화 억제제
FR2831395B1 (fr) * 2001-10-25 2004-06-11 Triballat Laiteries Procede de fabrication de produits fermentes a base de soja, produits fermentes obtenus par ce procede et ferments correspondants
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
CN1207382C (zh) * 2003-04-11 2005-06-22 上海光明乳业股份有限公司 植物乳杆菌st－iii菌株及其在调节血脂方面的应用
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
GB0424552D0 (en) * 2004-11-05 2004-12-08 Cambridge Theranostics Ltd Methods and means
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
KR100909586B1 (ko) * 2007-06-01 2009-07-27 신현길 혈중 콜레스테롤 농도 저하에 효과적인 유산균 및 이들의혼합균주
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
JP5469873B2 (ja) * 2008-03-11 2014-04-16 株式会社日立製作所 回転電機
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
JP5140791B2 (ja) * 2008-11-27 2013-02-13 森下仁丹株式会社 乳酸菌含有血中ホモシステイン低減剤
US9474773B2 (en) 2009-02-18 2016-10-25 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
ES2729765T3 (es) * 2009-06-19 2019-11-06 Dupont Nutrition Biosci Aps Bifidobacterias para el tratamiento de la insuficiencia cardíaca congestiva
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102031229B (zh) * 2009-09-24 2012-05-30 家医国际生化股份有限公司 具有肠胃道吸附能力及排除胆固醇能力的植物乳杆菌
PL2521769T3 (pl) * 2010-01-08 2017-01-31 Gervais Danone Sa Pałeczki kwasu mlekowego z działaniem przeciwutleniającym
GB201319540D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201319538D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
CN110786435B (zh) * 2019-11-19 2022-08-23 四川农业大学 产高活性纤溶酶原激活剂的植物乳杆菌及用其发酵的果蔬汁饮料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647551B2 (ja) * 1986-12-01 1994-06-22 株式会社ヤクルト本社 血圧降下剤
JP2676250B2 (ja) * 1989-03-20 1997-11-12 株式会社ヤクルト本社 血圧降下剤およびその製造法
JP2855290B2 (ja) * 1990-11-30 1999-02-10 株式会社ヤクルト本社 脂質代謝改善剤
JPH04264034A (ja) * 1991-02-18 1992-09-18 Snow Brand Milk Prod Co Ltd 生体内過酸化脂質抑制剤
JPH0525055A (ja) * 1991-07-22 1993-02-02 Yakult Honsha Co Ltd 血圧降下剤
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JPH06116155A (ja) * 1992-10-08 1994-04-26 Yakult Honsha Co Ltd 血清コレステロール低下剤
JP2801479B2 (ja) * 1992-10-09 1998-09-21 株式会社トクヤマ 補綴材料の製造方法
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
JPH08208512A (ja) * 1995-02-03 1996-08-13 Nippon Chem Res Kk 血栓形成阻害剤

Also Published As

Publication number Publication date
DE69834560T2 (de) 2006-11-02
JP4651814B2 (ja) 2011-03-16
EP0990024A1 (en) 2000-04-05
AU8372698A (en) 1999-03-01
SE510753C2 (sv) 1999-06-21
NO20000268L (no) 2000-01-19
EP0990024B1 (en) 2006-05-17
AR016798A1 (es) 2001-08-01
DE69834560D1 (de) 2006-06-22
KR20010022617A (ko) 2001-03-26
US6214336B1 (en) 2001-04-10
BR9811825A (pt) 2000-08-15
CN1142995C (zh) 2004-03-24
JP2001512747A (ja) 2001-08-28
ES2259457T3 (es) 2006-10-01
NO20000268D0 (no) 2000-01-19
CN1265141A (zh) 2000-08-30
NO324881B1 (no) 2007-12-27
NZ502610A (en) 2000-12-22
SE9702860D0 (sv) 1997-08-05
CA2297023C (en) 2010-03-30
PL194697B1 (pl) 2007-06-29
AU729413B2 (en) 2001-02-01
WO1999007827A1 (en) 1999-02-18
ZA986769B (en) 1999-02-02
CA2297023A1 (en) 1999-02-18
KR100517755B1 (ko) 2005-09-30
SE9702860L (sv) 1999-02-06
PL338578A1 (en) 2000-11-06
ATE326524T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
IL134113A0 (en) Use of lactobacillus for reduction of the fibrinogen level in blood
IL125756A (en) Catheter for use in surgery
EP1049636A4 (en) FIRST AID KIT
EP0879013A4 (en) MEDICAL GUIDE WIRE
PL318760A1 (en) Spiroazabicyclo compounds useful in medical treatment
SG77198A1 (en) Disposable absorbent article
GB2321719B (en) Liquid treatment
HUP0103150A3 (en) Disposable absorbant article
IL135947A0 (en) Human blood bacterium
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
GB9802599D0 (en) Medical use
HUP0000873A3 (en) The use of levobupivacaine in facial surgery
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same
GB2334677B (en) Bactericides and cleaning agents containing the same
GB9414157D0 (en) Medical use
IL113992A0 (en) Use of copolymer-1
ZA971419B (en) Macrocyclic peptides useful in the treatment of thrombin related disorders
GB9607201D0 (en) Medical article
HUP9800247A3 (en) Promoter for human endoglingene and its use
AU2713797A (en) Depigmentating agent in the treatment of melasma
SG71026A1 (en) Medical article
EP0941105A4 (en) PRE-TRAUMATIC USE OF HEMOGLOBIN
GB9617550D0 (en) Medical ice-pack
GB9601042D0 (en) Medical use
GB9711642D0 (en) Disposable tissue or towel used in the home

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired